Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
14%
OVERLAP
BY WEIGHT
15
# OF OVERLAPPING
HOLDINGS
CANC
55
HOLDINGS
27%
ALSO IN SBIO
SBIO
84
HOLDINGS
18%
ALSO IN CANC
SECTOR DRIFT (CANC minus SBIO)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in SBIO |
Overlap | |
|---|---|---|---|---|
 |
CG ONCOLOGY, INC. | 2.4% | 3.8% | 2.4% |
|
RELAY THERAPEUTICS, INC. | 2.2% | 2.7% | 2.2% |
|
IDEAYA BIOSCIENCES, INC. | 2.2% | 2.1% | 2.1% |
 |
ZAI LAB LTD. UNSPONSORED ADR | 1.6% | 1.7% | 1.6% |
|
IMMUNOME, INC. | 2.3% | 1.4% | 1.4% |
CANC Overweight Relative to SBIO
 |
GENMAB A/S SPONSORED ADR | 5.7% |
|
ELI LILLY & CO | 5.3% |
|
REVOLUTION MEDICINES, INC. | 5.2% |
|
MERCK & CO. INC. | 5.2% |
|
COGENT BIOSCIENCES INC | 4.5% |
 |
NOVARTIS AG | 4.2% |
|
ABBVIE INC | 4.0% |
|
HALOZYME THERAPEUTICS INC | 3.8% |
|
BEIGENE LTD. SPONSORED ADR | 3.7% |
|
EXELIXIS INC | 3.6% |
CANC Underweight Relative to SBIO
|
ORUKA THERAPEUTICS INC | -4.3% |
|
VERADERMICS INC | -3.9% |
|
DEFINIUM THERAPEUTICS INC | -3.2% |
|
TRAVERE THERAPEUTICS, INC. | -3.2% |
|
DIANTHUS THERAPEUTICS INC | -3.1% |
|
EDGEWISE THERAPEUTICS, INC. | -2.8% |
|
AMYLYX PHARMACEUTICALS, INC. | -2.4% |
|
ACADIA PHARMACEUTICALS INC | -2.4% |
|
TARSUS PHARMACEUTICALS, INC. | -2.2% |
|
DYNE THERAPEUTICS INC | -2.1% |